• Beijing Biostar Pharmaceuticals completed a private placement, issuing 25,000,000 new shares at HK$ 4 per share on July 16, 2026.
• Gross proceeds totaled HK$ 100 million; total shares outstanding rose to 389,588,000 from 364,588,000.
• The subscriber’s stake increased to 29,170,800 shares, equal to 7.49%, from 4,170,800 shares, or 1.14%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Beijing Biostar Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260716-12246672), on July 16, 2026, and is solely responsible for the information contained therein.